LFSC ETF (F/m Emerald Life Sciences Innovation ETF) is managed by Emerald ETF with $93.8M in net assets. LFSC expense ratio is 0.54%, holding 40 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2024-10-30.

LFSC performance shows a YTD return of -1.64%. The 1-year return is 36.35%.

LFSC top holdings include Cogent Biosciences Inc (8.9%), Livanova Plc (7.2%), Mirum Pharmaceuticals Inc (5.4%), Guardant Health, Inc (5.3%), Wave Life Sciences Ltd (5.2%). View all LFSC holdings, sector breakdown, or dividend history.

LFSC can be compared against other funds using the overlap calculator or side-by-side comparison tool. LFSC alternatives are available via the screener, along with tax-loss harvesting opportunities.